Key result
Successful PTCA carries a ~30% restenosis risk within six months despite current preventive techniques.
Population
Patients undergoing successful percutaneous transluminal coronary angioplasty (PTCA)
Design
Review
Follow-up
4 to 6 months (initial), 3 to 8 years (long-term)
Authors
Loading...
Restenosis limits PTCA durability without proven prevention; leaves open targeted research into antiproliferative strategies.
Restenosis remains a significant limitation of PTCA occurring in 25-30% of patients, driven by fibrocellular proliferation, with no effective preventive strategies currently available.
Kenneth M. Kent (1988) conducted a review in Restenosis after percutaneous transluminal coronary angioplasty. Percutaneous transluminal coronary angioplasty (PTCA) was evaluated on Restenosis. Restenosis after successful percutaneous transluminal coronary angioplasty occurs in 25 to 30% of patients within 4 to 6 months, with no current techniques proving effective in reducing its incidence.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: